UPCOMING SESSIONS in ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next Heather Landau Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions

Healthcare Professionals

teresa_de_marco
Teresa De Marco, MD
Dr. Teresa De Marco is director of advanced heart failure and pulmonary hypertension for University of California San Francisco (UCSF), as well as medical director…
Read more
suzanne_lentzsch
Suzanne Lentzsch, MD, PhD
Dr. Suzanne Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and…
Read more
sperry_brett
Brett W. Sperry, MD
Dr. Brett W. Sperry is a cardiologist at Saint Luke's Mid America Heart Institute with a subspecialty in advanced heart failure, transplantation, and mechanical…
Read more
mathew_maurer
Mathew S. Maurer, MD
Dr. Mathew S. Maurer is medical director of The Hypertrophic cardiomyopathy (HCM) Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. A…
Read more
rodney_falk
Rodney H. Falk, MD
Dr. Rodney H. Falk is the Director of the Cardiac Amyloidosis Program and a cardiovascular medicine specialist at Brigham and Women's Hospital (BWH). He is also an…
Read more
Subscribe to